Icosavax, Inc. Common Stock
ICVX
ICVX was delisted on the 16th of February, 2024.
42 hedge funds and large institutions have $670M invested in Icosavax, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 42 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$196M |
| 2 |
ASP
Adams Street Partners
Chicago,
Illinois
|
+$115M |
| 3 |
PA
Perceptive Advisors
New York
|
+$65.2M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$62.8M |
| 5 |
BlackRock
New York
|
+$53.5M |
Top Sellers
ICVX Hedge Fund Activity: Q3 2021 in Review
42 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Icosavax, Inc. Common Stock (ICVX) for Q3 2021, worth a combined $670M.
Buyers outnumbered sellers: 42 funds opened new ICVX positions and 0 closed out — a net gain of 42 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was RA Capital Management, opening a new position worth an estimated $196M.
- 42 institutional investors held Icosavax, Inc. Common Stock (ICVX) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $670M of Icosavax, Inc. Common Stock stock for Q3 2021.
- 42 funds opened new Icosavax, Inc. Common Stock positions in Q3 2021 and 0 closed out, a net change of +42 holders.
- The largest Icosavax, Inc. Common Stock buyer in Q3 2021 was RA Capital Management, an estimated $196M added.
Based on aggregated 13F filings for Q3 2021.